Royal Pharmaceutical Society (RPS) - News updates

Certain pages on this news feed are only available to RPS members and hence requires members to log-in accordingly

Get involved in promoting pharmacy in the General Election

The upcoming General Election on 12 December offers you the opportunity to have your say and help make the voice of the profession heard. Would you like to contact your local constituency candidates

Class 2 medicines recall: Omeprazole 40 mg powder for solution for infusion

Sandoz Limited is recalling one batch of omeprazole 40 mg powder for solution for infusion due to the occurrence of degradation in some vials, resulting in green discoloration of the powder in the via

RPS welcomes NICE guidance on cannabis-based medicinal products

Welcoming new NICE guidance on cannabis-based medicinal products published today, RPS Chief Scientist Gino Martini said: “It’s excellent news for patients that two cannabis-based medicine

Amendments to Serious Shortage Protocols for fluoxetine 40mg capsules (England)

The Serious Shortage Protocols (SSP) for fluoxetine 40mg capsules ...

Class 2 Medicines Recall: Kyowa Kirin Limited Mitomycin-C Kyowa, All Strengths (EL(19)A/33)

Kyowa Kirin Ltd is recalling all unexpired batches of the products as a precautionary measure due to deviations from the aseptic manufacturing processes during the manufacture of the sterile active ph

New home for RPS in Scotland

We’re pleased to announce that after months of renovation, weeks of packing and a busy few days of unpacking, the RPS in Scotland has now officially moved to its new home in Edinburgh’s Ne

Planning our pharmacy inclusion and diversity strategy with you

We’re a diverse profession, but we want to be a more inclusive one. That’s why we are working with you to create a sense of belonging, and inspire change across the pharmacy profession. T

Shortage of procyclidine (Kemadrin) 5mg/ml injection

Accord is the sole supplier of procyclidine injection in the UK and will be out of stock until March 2020. A shortage memo has been issued.

RPS writes to Health Secretary calling for pharmacist health and wellbeing support

In October, weresponded to the announcement by the Department of Health and Social Care that the NHS Practitioner Health service would be expanding to support all doctors and dentists with their wellb

Class 2 medicines recall: paracetamol 500 mg tablets

M & A Pharmachem is recallingspecific batches of paracetamol 500mg tablets as a precautionary measure. A small number of pots from some batches have been found to contain discoloured tablets due t